Healthy Subjects

Healthy/Normal·MeSH: Insulin Resistance

25 drugs in development·7 companies·16 clinical trials

Drug Pipeline by Phase

Phase 3(2)

Drug	Company
ac-076 for s.c. administration	Innovation Pharmaceuticals Inc. (IPIX)
cenerimod	Innovation Pharmaceuticals Inc. (IPIX)

Phase 2(4)

Drug	Company
act-246475	Innovation Pharmaceuticals Inc. (IPIX)
selatogrel	Innovation Pharmaceuticals Inc. (IPIX)
tnx-102 sl	Tonix Pharmaceuticals Holding Corp. (TNXP)
tnx-1500	Tonix Pharmaceuticals Holding Corp. (TNXP)

Phase 1(14)

Drug	Company
ac-076 for s.c. administration	Viatris Inc (VTRS)
act-246475	Viatris Inc (VTRS)
act-334441	Viatris Inc (VTRS)
ALPHA-1062 original nasal formulation (Phase I studies)	Alpha Cognition Inc. (ACOG)
combined oral contraceptives	Innovation Pharmaceuticals Inc. (IPIX)
combined oral contraceptives	Viatris Inc (VTRS)
diltiazem er	Viatris Inc (VTRS)
diltiazem er	Innovation Pharmaceuticals Inc. (IPIX)
hec-007	SUNSHINE BIOPHARMA INC. (SBFM)
keyhole limpet hemocyanin	Tonix Pharmaceuticals Holding Corp. (TNXP)
moxifloxacin	Viatris Inc (VTRS)
moxifloxacin	Innovation Pharmaceuticals Inc. (IPIX)
selatogrel	Viatris Inc (VTRS)
shr-4597	NYMOX PHARMACEUTICAL CORP (NYMXF)

Phase 1/Phase 2(5)

Drug	Company
act-334441	Innovation Pharmaceuticals Inc. (IPIX)
BEAM-103	Beam Therapeutics Inc. (BEAM)
BEAM-104	Beam Therapeutics Inc. (BEAM)
BEAM-301	Beam Therapeutics Inc. (BEAM)
BEAM-304	Beam Therapeutics Inc. (BEAM)

BioSniper tracks 25 drugs in development for Healthy Subjects across 7 companies.

There are 16 clinical trials targeting Healthy Subjects tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.